Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma

por Kalbasi, Anusha, Rengan, Ramesh
Publicado en Transl Lung Cancer Res (2017)

Antigen Presentation Keeps Trending in Immunotherapy Resistance

por Kalbasi, Anusha, Ribas, Antoni
Publicado en Clin Cancer Res (2018)

Functio Laesa: Cancer Inflammation and Therapeutic Resistance

por Liu, Mingen, Kalbasi, Anusha, Beatty, Gregory L.
Publicado en J Oncol Pract (2017)

How Technology Is Improving the Multidisciplinary Care of Sarcoma

por Schaefer, Inga-Marie, Hong, Kelvin, Kalbasi, Anusha
Publicado en Am Soc Clin Oncol Educ Book (2020)

Radiation and immunotherapy: a synergistic combination

por Kalbasi, Anusha, June, Carl H., Haas, Naomi, Vapiwala, Neha
Publicado 2013

Prevention of Interleukin-2 Withdrawal-Induced Apoptosis in Lymphocytes Retrovirally Cotransduced With Genes Encoding an Antitumor T-cell Receptor and an Antiapoptotic Protein

por Kalbasi, Anusha, Shrimali, Rajeev K., Chinnasamy, Dhanalakshmi, Rosenberg, Steven A.
Publicado en J Immunother (2010)

Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach

por Campbell, Katie M., Steiner, Gabriela, Wells, Daniel K., Ribas, Antoni, Kalbasi, Anusha
Publicado en bioRxiv (2020)

Low Rates of Adjuvant Radiation in Patients With Nonmetastatic Prostate Cancer With High-Risk Pathologic Features

por Kalbasi, Anusha, Swisher-McClure, Samuel, Mitra, Nandita, Sunderland, Robert, Smaldone, Marc C., Uzzo, Robert G., Bekelman, Justin E.
Publicado en Cancer (2014)

Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma

por Kalbasi, Anusha, Komar, Chad, Tooker, Graham M., Liu, Mingen, Lee, Jae W., Gladney, Whitney L., Ben-Josef, Edgar, Beatty, Gregory L.
Publicado en Clin Cancer Res (2016)

Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy

por Nesseler, Jean Philippe, Lee, Mi-Heon, Nguyen, Christine, Kalbasi, Anusha, Sayre, James W., Romero, Tahmineh, Nickers, Philippe, McBride, William H., Schaue, Dörthe
Publicado en Cancers (Basel) (2020)

Interleukin 32 expression in human melanoma

por Paz, Helicia, Tsoi, Jennifer, Kalbasi, Anusha, Grasso, Catherine S., McBride, William H., Schaue, Dörthe, Butterfield, Lisa H., Maurer, Deena M., Ribas, Antoni, Graeber, Thomas G., Economou, James S.
Publicado en J Transl Med (2019)

Clinical Development and Evaluation of Megavoltage Topogram for Fast Patient Alignment on Helical Tomotherapy

por Qi, X. Sharon, Chu, Fang-I., Zhang, Zhe, Chin, Robert K., Raldow, Ann, Kishan, Amar U., Lee, Percy, Chang, Albert, Kalbasi, Anusha, Kamrava, Mitchell, Steinberg, Michael L., Low, Daniel A.
Publicado en Adv Radiat Oncol (2020)

Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma

por Graham, Danielle S., van Dams, Ritchell, Jackson, Nicholas J., Onyshchenko, Mykola, Eckardt, Mark A., DiPardo, Benjamin J., Nelson, Scott D., Chmielowski, Bartosz, Shabason, Jacob E., Singh, Arun S., Eilber, Fritz C., Kalbasi, Anusha
Publicado en Cancers (Basel) (2020)

SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

por Ribas, Antoni, Medina, Theresa, Kummar, Shivaani, Amin, Asim, Kalbasi, Anusha, Drabick, Joseph J., Barve, Minal, Daniels, Gregory A., Wong, Deborah J., Schmidt, Emmett V., Candia, Albert F., Coffman, Robert L., Leung, Abraham C.F., Janssen, Robert S.
Publicado en Cancer Discov (2018)

A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

por Xie, Chong, Kim, Hyun J, Haw, Jonathan G, Kalbasi, Anusha, Gardner, Brian K, Li, Gang, Rao, Jianyu, Chia, David, Liong, Monty, Punzalan, Rubio R, Marks, Leonard S, Pantuck, Allan J, de la Taille, Alexandre, Wang, Guomin, Mukouyama, Hideki, Zeng, Gang
Publicado 2011

A Phase 2 Trial of Five-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma

por Kalbasi, Anusha, Kamrava, Mitchell, Chu, Fang-I, Telesca, Donatello, Van Dams, Ritchell, Yang, Yingli, Ruan, Dan, Nelson, Scott D., Dry, Sarah M., Hernandez, Jackie, Chmielowski, Bartosz, Singh, Arun S., Bukata, Susan V., Bernthal, Nicholas M., Steinberg, Michael L., Weidhaas, Joanne B., Eilber, Fritz C.
Publicado en Clin Cancer Res (2020)

Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Cl...

por Russell, Tara A., Eckardt, Mark A., Murakami, Takashi, Elliott, Irmina A., Kawaguchi, Kei, Kiyuna, Tasuku, Igarashi, Kentaro, Li, Yungfeng, Crompton, Joseph G., Graham, Danielle S., Dry, Sarah M., Bernthal, Nicholas, Yanagawa, Jane, Kalbasi, Anusha, Federman, Noah, Chmielowski, Bartosz, Singh, Arun S., Hoffman, Robert M., Eilber, Fritz C.
Publicado en JCO Precis Oncol (2017)

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

por Kalbasi, Anusha, Tariveranmoshabad, Mito, Hakimi, Kevin, Kremer, Sarah, Campbell, Katie M., Funes, Juan M., Vega-Crespo, Agustin, Parisi, Giulia, Champekar, Ameya, Nguyen, Christine, Torrejon, Davis, Shin, Daniel, Zaretsky, Jesse M., Damoiseaux, Robert D., Speiser, Daniel E., Lopez-Casas, Pedro P., Quintero, Marisol, Ribas, Antoni
Publicado en Sci Transl Med (2020)

A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination With or Without Ipilimumab

por Nowicki, Theodore S., Berent-Maoz, Beata, Cheung-Lau, Gardenia, Huang, Rong Rong, Wang, Xiaoyan, Tsoi, Jennifer, Kaplan-Lefko, Paula, Paula Cabrera, Tran, Justin, Pang, Jia, Macabali, Mignonette, Garcilazo, Ivan Perez, Carretero, Ignacio Baselga, Kalbasi, Anusha, Cochran, Alistair J., Grasso, Catherine S., Hu-Lieskovan, Siwen, Chmielowski, Bartosz, Comin-Anduix, Begoña, Singh, Arun, Ribas, Antoni
Publicado en Clin Cancer Res (2018)

Overcoming genetically-based resistance mechanisms to PD-1 blockade

por Torrejon, Davis Y., Abril-Rodriguez, Gabriel, Champhekar, Ameya S., Tsoi, Jennifer, Campbell, Katie M., Kalbasi, Anusha, Parisi, Giulia, Zarestsky, Jesse M., Garcia-Diaz, Angel, Puig-Saus, Cristina, Cheung-Lau, Gardenia, Wohlwender, Thomas, Krystofinski, Paige, Vega-Crespo, Agustin, Lee, Christopher M., Mascaro, Pau, Grasso, Catherine S., Berent-Maoz, Beata, Comin-Anduix, Begoña, Hu-Lieskovan, Siwen, Ribas, Antoni
Publicado en Cancer Discov (2020)